Jacobs Levy Equity Management, Inc Ironwood Pharmaceuticals Inc Transaction History
Jacobs Levy Equity Management, Inc
- $24.7 Billion
- Q3 2024
A detailed history of Jacobs Levy Equity Management, Inc transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 4,265,100 shares of IRWD stock, worth $15.1 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
4,265,100
Previous 4,358,298
2.14%
Holding current value
$15.1 Million
Previous $28.4 Million
38.31%
% of portfolio
0.07%
Previous 0.12%
Shares
13 transactions
Others Institutions Holding IRWD
# of Institutions
238Shares Held
162MCall Options Held
11.2MPut Options Held
9.1K-
Black Rock Inc. New York, NY22.9MShares$80.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA22MShares$77.8 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$57.9 Million16.75% of portfolio
-
Pacer Advisors, Inc. Malvern, PA11.3MShares$39.8 Million0.11% of portfolio
-
State Street Corp Boston, MA9.92MShares$35 Million0.0% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $541M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...